Arcturus Therapeutics Holdings Inc. (ARCT) vs Cypherpunk Technologies Inc. (CYPH)

Arcturus Therapeutics Holdings Inc. and Cypherpunk Technologies Inc. are both Biotechnology companies. Arcturus Therapeutics Holdings Inc. and Cypherpunk Technologies Inc. are of similar size ($325.5M and $320.3M). Arcturus Therapeutics Holdings Inc. has negative trailing earnings, so its P/E is not meaningful; Cypherpunk Technologies Inc. trades at 4.4×. Cypherpunk Technologies Inc. grew revenue faster over the last twelve months: 0.00% against −76.0%. Cypherpunk Technologies Inc. has the higher net margin (0.00% vs −317.6%) and the lower return on invested capital (−8.44% vs 0.00%). Across the 16 metrics below, Cypherpunk Technologies Inc. leads on 11 and Arcturus Therapeutics Holdings Inc. on 5.

Valuation

Metric ARCT CYPH Biotechnology median
P/E n/m 4.36 8.50
P/S 10.01 315.82 9.71
P/B 1.71 3.40 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 6.06 310.73 9.21
Earnings yield (32.01%) 22.96% (33.15%)
Free cash flow yield (24.76%) (4.44%) (25.50%)

Profitability

Metric ARCT CYPH Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (348.32%) 0.00% 0.00%
Net margin (317.61%) 0.00% 0.00%
Free cash flow margin (247.79%) 0.00% 0.00%
Return on equity (46.31%) (1.21%) (56.36%)
Return on assets (34.96%) (1.08%) (48.04%)
Return on invested capital 0.00% (8.44%) 0.00%

Growth

Metric ARCT CYPH Biotechnology median
Revenue growth (TTM) (75.95%) 0.00% 6.02%
EPS growth (last fiscal year) 20.00% 103.87% 30.26%
Revenue growth, 5-year CAGR 53.78% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARCT CYPH Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.88 79.19 4.72
Net debt to EBITDA 3.15 0.34 0.96

Dividend

Metric ARCT CYPH Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ARCT CYPH Biotechnology median
Market cap 320.32m 325.45m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack